Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
- DOI
- 10.1212/wnl.0000000000207770
- Published
- 2023 Nov 7
- Container
- Neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1212/wnl.0000000000207770,
title = {Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.},
author = {Pittock RR and Aakre JA and Castillo AM and Ramanan VK and Kremers WK and Jack CR Jr and Vemuri P and Lowe VJ and Knopman DS and Petersen RC and Graff-Radford J and Vassilaki M},
year = {2023},
journal = {Neurology},
doi = {10.1212/wnl.0000000000207770},
url = {https://doi.org/10.1212/wnl.0000000000207770}
}RIS
TY - JOUR TI - Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. AU - Pittock RR AU - Aakre JA AU - Castillo AM AU - Ramanan VK AU - Kremers WK AU - Jack CR Jr AU - Vemuri P AU - Lowe VJ AU - Knopman DS AU - Petersen RC AU - Graff-Radford J AU - Vassilaki M PY - 2023 JO - Neurology DO - 10.1212/wnl.0000000000207770 UR - https://doi.org/10.1212/wnl.0000000000207770 ER -
APA
RR, P., JA, A., AM, C., VK, R., WK, K., Jr, J. C., P, V., VJ, L., DS, K., RC, P., J, G., & M, V. (2023). Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.. Neurology. https://doi.org/10.1212/wnl.0000000000207770
Source records
- pubmed · retrieved 2026-09-27T14:08:35.223Z